To examine, in patients with gout using escalating urate-lowering therapy (ULT), the treatment duration and allopurinol dose required to attain the serum urate (SU) target (< 360 μmol/L; < 6 mg/dL).
Scandinavian journal of rheumatology
Journal Article
English
42021592
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.